HHS Rebate Plan A Leap Of Faith? Lower Costs Hinge On Drug Firm, Plan Response
Executive Summary
HHS seeks input on how stakeholders might adjust to a system without rebates and requests comments on three actuarial reports that attempt to project the financial impact of the change.
You may also be interested in...
Medicare Part D Drug Rebate Rule Finally Sees Light Of Day: Now What?
Assurances from HHS Secretary Azar that rule will not significantly raise premiums and federal spending amount to a request to ‘just trust me.’
Medicare Part D Spending in 2019 Lower Than Expected Because Of Rebates
Medicare Trustees Report highlights importance of rebates in Part D but does not address potential changes to system; charts detail the growing impact rebates are expected to have in coming years.
CMS Offers Part D Plans Financial Backstop If Rebates Eliminated In 2020
But CMS also advises Medicare Part D plans to develop bids for the 2020 plan year that include rebates, since the final version of the HHS rule eliminating the anti-kickback safe harbor for rebates may not be released in time for the June 3 bid submission deadline.